Lo Simon K, Mehdizadeh Shahab
Digestive Disease Center, Cedar-Sinai Medical Center, 8700 Beverly Boulevard, Room 7511, Los Angeles, CA 90048, USA.
Gastrointest Endosc Clin N Am. 2006 Apr;16(2):363-76. doi: 10.1016/j.giec.2006.03.002.
In spite of initial skepticism toward the practicability of double-balloon enteroscopy, this technology will become an integral part of endoscopy and is likely to find expanded applications in the future. One strong reason to support this technique is the capacity to deliver endoscopic therapies, and thereby minimize aggressive surgical options. With increasing acceptance of capsule endoscopy by the medical community, more small-bowel lesions will be found and more directed endoscopic interventions will be needed. Like many new procedures, reimbursement issues will possibly prevent it from gaining well-deserved popularity. Unlike other common endoscopies, double-balloon enteroscopy is an expensive procedure. It requires fluoroscopy, extended anesthesia support, long procedure time, significant capital investment, and a team of threeor four people (endoscopist, anesthesiologist, nurse). Gastroenterologists and their patients will have to work together to convince insurance carriers that this isa valuable and cost-effective technology worthy of appropriate reimbursement.
尽管最初人们对双气囊小肠镜检查的实用性持怀疑态度，但这项技术将成为内镜检查不可或缺的一部分，并且未来可能会得到更广泛的应用。支持这项技术的一个重要原因是其能够进行内镜治疗，从而减少激进的手术选择。随着医学界对胶囊内镜的接受度不断提高，将会发现更多的小肠病变，并且需要更多有针对性的内镜干预。与许多新的手术一样，报销问题可能会阻碍它获得应有的普及。与其他常见的内镜检查不同，双气囊小肠镜检查是一种昂贵的手术。它需要荧光透视、长时间的麻醉支持、较长的手术时间、大量的资金投入以及一个由三四人组成的团队（内镜医师、麻醉师、护士）。胃肠病学家和他们的患者必须共同努力，说服保险公司相信这是一项有价值且具有成本效益的技术，值得给予适当的报销。
